BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35299043)

  • 41. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cervical cancer and Pap smear screening in Botswana: knowledge and perceptions.
    McFarland DM
    Int Nurs Rev; 2003 Sep; 50(3):167-75. PubMed ID: 12930285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comprehensive study on the multi-class cervical cancer diagnostic prediction on pap smear images using a fusion-based decision from ensemble deep convolutional neural network.
    Hussain E; Mahanta LB; Das CR; Talukdar RK
    Tissue Cell; 2020 Aug; 65():101347. PubMed ID: 32746984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The determination of the knowledge level and behavior of Turkish women from various occupations about human papillomavirus, cervical cancer, and pap smear test.
    Cimke VS; Borekci G
    J Cancer Res Ther; 2019; 15(6):1235-1244. PubMed ID: 31898654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Collection of cervical secretions does not adversely affect Pap smears taken immediately afterward.
    Hildesheim A; Bratti MC; Edwards RP; Schiffman M; Rodriguez AC; Herrero R; Alfaro M; Morera LA; Ermatinger SV; Miller BT; Crowley-Nowick PA
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):491-3. PubMed ID: 9665954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Study Of Agreement Between Visual Inspection With Acetic Acid Of Cervix And Pap Smear For Cervical Cancer Screening.
    Ara C; Inayat K; Hanif A; Afsar S; Ullah I
    J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S668-S670. PubMed ID: 30838828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome after a Pap smear report of low-grade abnormality: a longitudinal comparative study.
    Mitchell H
    Aust N Z J Obstet Gynaecol; 1999 Aug; 39(3):345-8. PubMed ID: 10554949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A fuzzy rank-based ensemble of CNN models for classification of cervical cytology.
    Manna A; Kundu R; Kaplun D; Sinitca A; Sarkar R
    Sci Rep; 2021 Jul; 11(1):14538. PubMed ID: 34267261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationships between Self-Efficacy and Pap Smear Screening in Iranian Women.
    Majdfar Z; Khodadost M; Majlesi F; Rahimi A; Shams M; Mohammadi G
    Asian Pac J Cancer Prev; 2016; 17(S3):263-8. PubMed ID: 27165236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A fuzzy distance-based ensemble of deep models for cervical cancer detection.
    Pramanik R; Biswas M; Sen S; Souza Júnior LA; Papa JP; Sarkar R
    Comput Methods Programs Biomed; 2022 Jun; 219():106776. PubMed ID: 35398621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
    Sumarmi S; Hsu YY; Cheng YM; Lee SH
    Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix.
    Dhakal R; Makaju R; Sharma S; Bhandari S; Shrestha S; Bastakoti R
    Kathmandu Univ Med J (KUMJ); 2016 Jul-Sept.; 14(55):254-257. PubMed ID: 28814689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of cervical-vaginal infections in the pap-smear samples in Iran.
    Maria C; Zahra R; Sara P
    Glob J Health Sci; 2013 Dec; 6(1):201-6. PubMed ID: 24373280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accuracy of Screening Tools for Pap Smears in General Practice.
    Harding C; Seal A; Pilotto L; Mackey K; Duncan G; Huynh R; McWilliam R; Blake S
    J Innov Health Inform; 2016 Sep; 23(3):835. PubMed ID: 28059690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Study of Smart Scope® Visual Screening Test with Naked Eye Visual Screening and Pap Test.
    Rahatgaonkar V; Uchale P; Oka G
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3509-3515. PubMed ID: 33369446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Present standards for cervical cancer screening.
    O'Meara AT
    Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accurate Cervical Cell Segmentation from Overlapping Clumps in Pap Smear Images.
    Song Y; Tan EL; Jiang X; Cheng JZ; Ni D; Chen S; Lei B; Wang T
    IEEE Trans Med Imaging; 2017 Jan; 36(1):288-300. PubMed ID: 27623573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
    Nassar A; Fleisher SR; Nasuti JF
    Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.